Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Vascular Anomalies and Treatments, Respiratory and Cough-Related Research, Pulmonary Hypertension Research and Treatments, and Vascular Malformations and Hemangiomas.
Pomalidomide for hereditary hemorrhagic telangiectasia: after trial longitudinal assessment study (PATH-HHT ATLAS).
Blood Pressure Variability (BPV) as a Novel Digital Biomarker of Multisystem Risk and Diagnostic Insight: Measurement, Mechanisms, and Emerging Artificial Intelligence Methods.
Characteristics associated with clinical response to pomalidomide in hereditary hemorrhagic telangiectasia.
Clinical Spectrum of Hereditary Hemorrhagic Telangiectasia: Data from the Comprehensive HHT Outcomes Registry of the US (CHORUS).
Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report.
Artificial Intelligence-Enhanced Liquid Biopsy and Radiomics in Early-Stage Lung Cancer Detection: A Precision Oncology Paradigm.
Embolotherapy for Pulmonary Arteriovenous Malformations in the Pediatric Population with Hereditary Hemorrhagic Telangiectasias-A Retrospective Case Series.
A Novel Unsupervised You Only Listen Once (YOLO) Machine Learning Platform for Automatic Detection and Characterization of Prominent Bowel Sounds Towards Precision Medicine.
Leveraging Artificial Intelligence for the Diagnosis of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: Opportunities, Challenges, and Future Perspectives.
Artificial Intelligence Enabled Lung Sound Auscultation in the Early Diagnosis and Subtyping of Interstitial Lung Disease.
The Human Voice as a Digital Health Solution Leveraging Artificial Intelligence.
Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data Analysis.
Executive summary of the 14th HHT international scientific conference.
Digital Pulmonology Practice with Phonopulmography Leveraging Artificial Intelligence: Future Perspectives Using Dual Microwave Acoustic Sensing and Imaging.
Neuropilin-1 deficiency in vascular smooth muscle cells is associated with hereditary hemorrhagic telangiectasia arteriovenous malformations.
Intensive Care Unit and Hospital Outcomes of Patients Admitted with Blastomycosis: A 14-Year Retrospective Study.
Outcomes of liver transplantation in patients with hepatopulmonary syndrome in the pre and post-MELD eras: A systematic review.
Intensive Care Unit and Hospital Outcomes of Patients Admitted with Blastomycosis: A 14-Year Retrospective Study
Stabbed in the Back! Neurosarcoidosis with Spinal Cord Involvement.
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study
Global Physiology and Pathophysiology of Cough
Intravenous Bevacizumab Reduces Transfusion Requirements and Endoscopic Interventions in Patients With Gastric Antral Vascular Ectasia and Small Bowel Angioectasia.
Pulmonary Arteriovenous Malformations in Non-hereditary Hemorrhagic Telangiectasia Patients: An 18-Year Retrospective Study.
Mobile Mitral and Aortic Valvular Masses in Patients With Hereditary Hemorrhagic Telangiectasia Receiving Intravenous Bevacizumab.
Preoperative Factors Predicting Admission to the Intensive Care Unit After Kidney Transplantation.
Physician Staffing Models Impact the Timing of Decisions to Limit Life Support in the ICU